SEC Filing Details
Document Details
Form
Filing Date
February 22, 2023
Document Date
February 20, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Filer
Lim Bryant David